Matrix Metalloproteinase 9
"Matrix Metalloproteinase 9" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V.
| Descriptor ID |
D020780
|
| MeSH Number(s) |
D08.811.277.656.300.480.205.360 D08.811.277.656.300.480.252.445 D08.811.277.656.300.480.525.700.350 D08.811.277.656.675.374.205.360 D08.811.277.656.675.374.252.445 D08.811.277.656.675.374.525.700.350 D12.644.276.848.350 D12.776.467.836.350
|
| Concept/Terms |
Matrix Metalloproteinase 9- Matrix Metalloproteinase 9
- Metalloproteinase 9, Matrix
- 92-kDa Type IV Collagenase
- 92 kDa Type IV Collagenase
- Matrix Metalloproteinase-9
- MMP9 Metalloproteinase
- Metalloproteinase, MMP9
- MMP-9 Metalloproteinase
- MMP 9 Metalloproteinase
- Metalloproteinase, MMP-9
- 92-kDa Gelatinase
- 92 kDa Gelatinase
- Gelatinase B
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 9".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 9".
This graph shows the total number of publications written about "Matrix Metalloproteinase 9" by people in this website by year, and whether "Matrix Metalloproteinase 9" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 1 | 3 |
| 2005 | 2 | 0 | 2 |
| 2006 | 3 | 1 | 4 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 3 | 4 |
| 2009 | 1 | 2 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 0 | 2 | 2 |
| 2014 | 0 | 3 | 3 |
| 2015 | 2 | 2 | 4 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Matrix Metalloproteinase 9" by people in Profiles.
-
Location-dependent heterotopic ossification in the rat model: The role of activated matrix metalloproteinase 9. J Orthop Res. 2016 11; 34(11):1894-1904.
-
Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease. JAMA Ophthalmol. 2015 Oct; 133(10):1117-23.
-
Biomarkers and mortality in severe Chagas cardiomyopathy. Glob Heart. 2015 Sep; 10(3):173-80.
-
Desiccating Stress-Induced MMP Production and Activity Worsens Wound Healing in Alkali-Burned Corneas. Invest Ophthalmol Vis Sci. 2015 Jul; 56(8):4908-18.
-
TGF?1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5. Lab Invest. 2015 Aug; 95(8):903-13.
-
Biomarkers in Trypanosoma cruzi-infected and uninfected individuals with varying severity of cardiomyopathy in Santa Cruz, Bolivia. PLoS Negl Trop Dis. 2014 Oct; 8(10):e3227.
-
WFDC1 is a key modulator of inflammatory and wound repair responses. Am J Pathol. 2014 Nov; 184(11):2951-64.
-
Osmoprotectants suppress the production and activity of matrix metalloproteinases induced by hyperosmolarity in primary human corneal epithelial cells. Mol Vis. 2014; 20:1243-52.
-
Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes. Oncotarget. 2014 Apr 30; 5(8):2208-20.
-
TGF-? modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer Res. 2013 Aug 15; 73(16):5016-28.